Transcend Medical, Inc. Completes Enrollment in Landmark Glaucoma Study Evaluating the CyPass® Micro-Stent
2/28/2013 9:18:09 AM
More...
|
Transcend Medical, Inc. Announces 12-Month European Study Results of the CyPass Micro-Stent® at American Academy of Ophthalmology 2012
11/13/2012 11:20:33 AM
More...
|
Transcend Medical, Inc. Announces Four Scientific Abstracts at the American Society of Cataract & Refractive Surgery Annual Meeting
4/23/2012 10:07:45 AM
More...
|
Transcend Medical, Inc. Closes $51 Million Series B Financing
7/14/2011 6:29:03 AM
More...
|
Transcend Medical, Inc. Expands Leadership Team Appointing Chief Medical Officer and Vice President of Clinical Affairs
8/31/2009 9:37:03 AM
More...
|
Transcend Medical, Inc. Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment
6/22/2009 9:41:27 AM
More...
|
Transcend Medical, Inc. Raises Second Round of Financing
6/5/2009 7:53:08 AM
More...
|
Transcend Medical, Inc. Announces New President and CEO and Appointment of Chairman of the Board
9/10/2008 6:56:44 AM
More...
|
Transcend Medical, Inc. Announces New CEO Appointment And Series 'A' Funding
11/10/2006 9:25:56 AM
More...
|